Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial (BaSE)
Primary Purpose
Obesity, Morbid, Surgery, Elderly
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Sleeve Gastrectomy
Gastric Bypass
Sponsored by
About this trial
This is an interventional treatment trial for Obesity, Morbid
Eligibility Criteria
Inclusion Criteria:
- BMI over 40 Kg/m2 for at least 5 years with failure of obesity medical treatments
- BMI over 35 Kg/m2 with at least 2 comorbidities and failure of medical treatments
Exclusion Criteria:
- prior bariatric surgery
- clinical or psychological conditions that contraindicate bariatric surgery
Sites / Locations
- Hospital das Clinicas da Faculdade de Medicina da USP
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Sleeve
Bypass
Arm Description
Morbid obese patients, 65 years old or more, submitted to Sleeve Gastrectomy
Morbid obese patients, 65 years old or more, submitted to Gastric Bypass
Outcomes
Primary Outcome Measures
Total Weight loss
Weight loss measured in percentage of weight loss (%WL)
Surgical Complications
Bleeding, Leakage, Fistula, Bowel obstruction
Mortality
mortality
Improvement of Type II diabetes
Measure of glycated hemoglobin
Improvement of hypertension
measure of blood pressure (mmHg)
Improvement of LDL
measure of LDL
Clinical complications
cardiac, pulmonary, other
Excess weight loss
excess weight loss (%EWL); considering the normal weight the equivalent to the BMI 25 Kg/m2
Improvement of hypertension by use of medication
evaluation of the number of drugs used to treat hypertension
Improvement of HDL
measure of HDL
Improvement of triglycerides
measure of triglycerides
Secondary Outcome Measures
Functionality
Functionality specific test (Activities of Day living)
Body composition
Dexa (Dual-energy X-ray absorptiometry) body composition study
Functionality
Functionality specific test (Instrumental activities of day living)
Functionality
Time up and go test
Full Information
NCT ID
NCT03339791
First Posted
October 30, 2017
Last Updated
December 1, 2020
Sponsor
University of Sao Paulo General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03339791
Brief Title
Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial
Acronym
BaSE
Official Title
Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass for Treatment of Severe Obesity in Patients With 65 Years or Older: a Randomized Controlled Trial - The "BaSE" Trial - Bariatric Surgery in the Elderly.
Study Type
Interventional
2. Study Status
Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
September 23, 2017 (Actual)
Primary Completion Date
November 7, 2017 (Actual)
Study Completion Date
July 16, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of the study is to compare two different bariatric procedures performed in patients with 65 years or more: gastric bypass and sleeve gastrectomy. Primary outcomes will be weight loss, control of comorbidities and morbidity of the operation. Secondary outcomes are related to functionality, that will be evaluated with specific tests.
Detailed Description
Introduction: Surgical treatment of obesity in patients over 65 years of age is controversial. For patients in this age group, there is a prevailing concept that the risk / benefit ratio of the procedure should be evaluated for each individual patient, without determining objective criteria or outcomes that characterize this benefit. Increased surgical risk in patients older than 65 years is undoubtedly a limiting factor for the broader indication of bariatric surgery in this population. The two most applied surgical techniques are Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Most of the studies that evaluated the two techniques in elderly patients are retrospective, prospective non-randomized, or contemplated only one technique. Recent, studies concluded that in the elderly the weight loss with Gastric Bypass was higher, but the surgical morbidity with the Sleeve was lower and there was no difference in the resolution of comorbidities between the two techniques. In evaluating the benefits of surgery, most studies address outcomes such as weight loss and control of metabolic and cardiovascular comorbidities. Outcomes that are specific to the treatment of obesity in the elderly, such as improvement of functionality, decreased fragility and improvement of the quality of life have not been studied yet. In this field, there is concern that excessive weight loss, accompanied by loss of muscle mass may compromise the mentioned parameters, especially in individuals who already have loss of bone and muscle mass before surgery. For this reason, the assessment of bone mass and body composition in the preoperative period of these individuals is fundamental. In order to identify the benefits of weight loss promoted by surgery and life expectancy, the elderly patients in preparation for operation at the Bariatric Surgery Unit of the Hospital das Clinicas University of São Paulo School of Medicine are submitted to a geriatric evaluation, which includes the analysis of their functional dependency profile, Important prognostic factor in this population. Objectives: The primary objective of the study will be to evaluate surgical morbidity and short-term (weight loss, comorbid control) outcomes of surgical treatment of obesity in patients over 65 years of age, comparing two techniques: Sleeve Gastrectomy (SG) and Gastric Bypass (GB). The secondary objective will be to evaluate the body composition of the individuals, before and after the surgery, comparing the two techniques. Patients and methods: This is a prospective study, in which 40 consecutive patients, aged 65 years and over, will be admitted to the Bariatric and Metabolic Surgery Unit of the Discipline of Digestive System Surgery of Hospital das Clinicas University of São Paulo School of Medicine with indication criteria for bariatric surgery. Patients will be randomized into two groups according to the surgical technique to be used: SG or GB. Data related to surgical morbidity, weight loss, control of comorbidities, nutritional deficiencies, changes in body composition and functionality will be evaluated and compared after a follow-up of at least 12 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Morbid, Surgery, Elderly
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
36 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sleeve
Arm Type
Active Comparator
Arm Description
Morbid obese patients, 65 years old or more, submitted to Sleeve Gastrectomy
Arm Title
Bypass
Arm Type
Active Comparator
Arm Description
Morbid obese patients, 65 years old or more, submitted to Gastric Bypass
Intervention Type
Procedure
Intervention Name(s)
Sleeve Gastrectomy
Other Intervention Name(s)
Vertical gastrectomy
Intervention Description
Laparoscopic Sleeve Gastrectomy. Technique: complete mobilization of the greater curvature and gastric fundus up to the angle of Hiss; stapling beginning at 3 to 4 cm away from the pylorus; bougie size 32 French; oversuture of the staple line; hiatoplasty in selected cases; routine drainage of the abdominal cavity
Intervention Type
Procedure
Intervention Name(s)
Gastric Bypass
Other Intervention Name(s)
Roux-en_y Gastric Bypass
Intervention Description
Laparoscopic Gastric Bypass. Technique: Pouch size 30 to 40 ml, biliopancreatic limb 70 to 100 cm, alimentary limb 100 to 120 cm, antecolic, routine closure of the mesenterial defects, routine drainage of the abdominal cavity
Primary Outcome Measure Information:
Title
Total Weight loss
Description
Weight loss measured in percentage of weight loss (%WL)
Time Frame
1 year
Title
Surgical Complications
Description
Bleeding, Leakage, Fistula, Bowel obstruction
Time Frame
30 days
Title
Mortality
Description
mortality
Time Frame
90 days
Title
Improvement of Type II diabetes
Description
Measure of glycated hemoglobin
Time Frame
baseline and 1 year
Title
Improvement of hypertension
Description
measure of blood pressure (mmHg)
Time Frame
baseline and 1 year
Title
Improvement of LDL
Description
measure of LDL
Time Frame
baseline and 1 year
Title
Clinical complications
Description
cardiac, pulmonary, other
Time Frame
30 days
Title
Excess weight loss
Description
excess weight loss (%EWL); considering the normal weight the equivalent to the BMI 25 Kg/m2
Time Frame
1 year
Title
Improvement of hypertension by use of medication
Description
evaluation of the number of drugs used to treat hypertension
Time Frame
baseline and 1 year
Title
Improvement of HDL
Description
measure of HDL
Time Frame
baseline and 1 year
Title
Improvement of triglycerides
Description
measure of triglycerides
Time Frame
baseline and 1 year
Secondary Outcome Measure Information:
Title
Functionality
Description
Functionality specific test (Activities of Day living)
Time Frame
baseline and 1 year
Title
Body composition
Description
Dexa (Dual-energy X-ray absorptiometry) body composition study
Time Frame
baseline and 1 year
Title
Functionality
Description
Functionality specific test (Instrumental activities of day living)
Time Frame
baseline and 1 year
Title
Functionality
Description
Time up and go test
Time Frame
baseline and 1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
BMI over 40 Kg/m2 for at least 5 years with failure of obesity medical treatments
BMI over 35 Kg/m2 with at least 2 comorbidities and failure of medical treatments
Exclusion Criteria:
prior bariatric surgery
clinical or psychological conditions that contraindicate bariatric surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Denis Pajecki
Organizational Affiliation
Hospital das Clinicas - Faculdade de Medicina da USP
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital das Clinicas da Faculdade de Medicina da USP
City
São Paulo
ZIP/Postal Code
05403-000
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The plan is to publish the complete data after the end of the study
Citations:
PubMed Identifier
26193177
Citation
Maghrabi AH, Wolski K, Abood B, Licata A, Pothier C, Bhatt DL, Nissen S, Brethauer SA, Kirwan JP, Schauer PR, Kashyap SR. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy. Obesity (Silver Spring). 2015 Dec;23(12):2344-8. doi: 10.1002/oby.21150. Epub 2015 Jul 20.
Results Reference
background
PubMed Identifier
26001882
Citation
Abbas M, Cumella L, Zhang Y, Choi J, Vemulapalli P, Melvin WS, Camacho D. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60. Obes Surg. 2015 Dec;25(12):2251-6. doi: 10.1007/s11695-015-1712-9.
Results Reference
background
PubMed Identifier
24760060
Citation
Pajecki D, Santo MA, Kanagi AL, Riccioppo D, de Cleva R, Cecconello I. Functional assessment of older obese patients candidates for bariatric surgery. Arq Gastroenterol. 2014 Jan-Mar;51(1):25-8. doi: 10.1590/s0004-28032014000100006.
Results Reference
background
PubMed Identifier
22118843
Citation
Strain GW, Gagner M, Pomp A, Dakin G, Inabnet WB, Saif T. Comparison of fat-free mass in super obesity (BMI >/= 50 kg/m2) and morbid obesity (BMI <50 kg/m2) in response to different weight loss surgeries. Surg Obes Relat Dis. 2012 May-Jun;8(3):255-9. doi: 10.1016/j.soard.2011.09.028. Epub 2011 Oct 20.
Results Reference
background
Learn more about this trial
Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial
We'll reach out to this number within 24 hrs